Cetera Investment Advisers Axsome Therapeutics, Inc. Transaction History
Cetera Investment Advisers
- $42.2 Billion
- Q2 2024
A detailed history of Cetera Investment Advisers transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 6,132 shares of AXSM stock, worth $574,384. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,132
Previous 5,675
8.05%
Holding current value
$574,384
Previous $452,000
9.07%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AXSM
# of Institutions
288Shares Held
40.4MCall Options Held
365KPut Options Held
428K-
Rtw Investments, LP New York, NY4.63MShares$434 Million6.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$351 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$309 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$221 Million37.71% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.85MShares$174 Million4.89% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.02B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...